New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results
BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma
St. Luke's International Hospital
Two-Drug Combination For Refractory Thyroid Cancer, 100% Effective!
Micro fluid device to avoid painful biopsy of patients with myeloma
New Treatment For Advanced Cervical Cancer Approved! Significant Improvement In Patient Survival
